Advanced Filter

Filter by Group

Filter by Market Availability

Did you mean 99016 4,5 9?
Displaying drugs 1301 - 1325 of 1922 in total
Investigational
Experimental
Matched Iupac: … [(2S)-2-[(9Z)-hexadec-9-enoyloxy]-3-[(9Z)-octadec-9-enoyloxy]propoxy](2-hydroxyethoxy)phosphinic acid …
DR-01 is a monoclonal antibody directed against human CD94.
Investigational
Onvansertib is under investigation in clinical trial NCT03303339 (Onvansertib in Combination With Either Low-dose Cytarabine or Decitabine in Adult Patients With Acute Myeloid Leukemia (AML).).
Investigational
Lunasine is under investigation in clinical trial NCT02709330 (ALS Reversals - Lunasin Regimen).
Investigational
Matched Iupac: … (2R)-4,8-dimethoxy-9-methyl-2-(propan-2-yl)-2H,3H-furo[2,3-b]quinolin-9-ium …
Investigational
Investigational
Selective inhibitor of SIRT1 that does not inhibit histone deacetylase (HDAC) or other sirtuin deacetylase family members (IC50 values are 98, 19600, 48700, > 100000 and > 100000 nM for SIRT1, SIRT2, SIRT3, HDAC and NADase respectively). Enhances p53 acetylation in response to DNA damaging agents.
Experimental
Experimental
Investigational
XR5944 is a DNA bis-intercalating anticancer drug. It has both intercalating and antineoplastic activities.
Investigational
Matched Iupac: … 9-methyl-N-(2-{[2-({2-[(9-methylphenazin-1-yl)formamido]ethyl}amino)ethyl]amino}ethyl)phenazine-1-carboxamide …
Experimental
Matched Iupac: … (9Z)-octadec-9-en-1-amine hydrofluoride …
Investigational
Experimental
Matched Iupac: … 4-(9H-carbazol-9-yl)butanoic acid …
Investigational
Matched Iupac: … (9Z)-N-(2-hydroxyethyl)octadec-9-enamide …
Displaying drugs 1301 - 1325 of 1922 in total